Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms

ABT-199 (venetoclax) is the first-in-class selective B-cell lymphoma 2 (BCL2) inhibitor, which is known to be ineffective towards liver cancer cells. Here, we investigated the efficacy and the underlying molecular processes of the sensitization effect of kaempferol isolated from persimmon leaves (KP...

Full description

Bibliographic Details
Main Authors: Chen, Li, Jiang, Xudong, Gao, Si, Liu, Xueping, Gao, Ying, Siew, Audrey Foong Kow, Tham, Chau Ling, Ming, Tatt Lee
Format: Article
Published: Frontiers Media 2022
Online Access:http://psasir.upm.edu.my/id/eprint/103172/
_version_ 1848863952162783232
author Chen, Li
Jiang, Xudong
Gao, Si
Liu, Xueping
Gao, Ying
Siew, Audrey Foong Kow
Tham, Chau Ling
Ming, Tatt Lee
author_facet Chen, Li
Jiang, Xudong
Gao, Si
Liu, Xueping
Gao, Ying
Siew, Audrey Foong Kow
Tham, Chau Ling
Ming, Tatt Lee
author_sort Chen, Li
building UPM Institutional Repository
collection Online Access
description ABT-199 (venetoclax) is the first-in-class selective B-cell lymphoma 2 (BCL2) inhibitor, which is known to be ineffective towards liver cancer cells. Here, we investigated the efficacy and the underlying molecular processes of the sensitization effect of kaempferol isolated from persimmon leaves (KPL) on the ABT-199-resistant HepG2 cells. The effects of various doses of KPL coupled with ABT-199 on the proliferation of HepG2 cells and on the H22 liver tumor-bearing mouse model were examined, as well as the underlying mechanisms. Our findings showed that ABT-199 alone, in contrast to KPL, had no significant impact on hepatoma cell growth, both in vitro and in vivo. Interestingly, the combination therapy showed significantly higher anti-hepatoma efficacy. Mechanistic studies revealed that combining KPL and ABT-199 may promote both early and late apoptosis, as well as decrease the mitochondrial membrane potential in HepG2 cells. Western blot analysis showed that combination of KPL and ABT-199 significantly reduced the expression of the anti-apoptotic proteins Bcl-2, Bcl-xL, and Mcl-1, raised the expression of Bax and cleaved caspase 3, and enhanced cytochrome C release and Bax translocation. Therefore, KPL combined with ABT-199 has a potential application prospect in the treatment of hepatocellular carcinoma.
first_indexed 2025-11-15T13:41:05Z
format Article
id upm-103172
institution Universiti Putra Malaysia
institution_category Local University
last_indexed 2025-11-15T13:41:05Z
publishDate 2022
publisher Frontiers Media
recordtype eprints
repository_type Digital Repository
spelling upm-1031722023-12-04T02:48:31Z http://psasir.upm.edu.my/id/eprint/103172/ Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms Chen, Li Jiang, Xudong Gao, Si Liu, Xueping Gao, Ying Siew, Audrey Foong Kow Tham, Chau Ling Ming, Tatt Lee ABT-199 (venetoclax) is the first-in-class selective B-cell lymphoma 2 (BCL2) inhibitor, which is known to be ineffective towards liver cancer cells. Here, we investigated the efficacy and the underlying molecular processes of the sensitization effect of kaempferol isolated from persimmon leaves (KPL) on the ABT-199-resistant HepG2 cells. The effects of various doses of KPL coupled with ABT-199 on the proliferation of HepG2 cells and on the H22 liver tumor-bearing mouse model were examined, as well as the underlying mechanisms. Our findings showed that ABT-199 alone, in contrast to KPL, had no significant impact on hepatoma cell growth, both in vitro and in vivo. Interestingly, the combination therapy showed significantly higher anti-hepatoma efficacy. Mechanistic studies revealed that combining KPL and ABT-199 may promote both early and late apoptosis, as well as decrease the mitochondrial membrane potential in HepG2 cells. Western blot analysis showed that combination of KPL and ABT-199 significantly reduced the expression of the anti-apoptotic proteins Bcl-2, Bcl-xL, and Mcl-1, raised the expression of Bax and cleaved caspase 3, and enhanced cytochrome C release and Bax translocation. Therefore, KPL combined with ABT-199 has a potential application prospect in the treatment of hepatocellular carcinoma. Frontiers Media 2022 Article PeerReviewed Chen, Li and Jiang, Xudong and Gao, Si and Liu, Xueping and Gao, Ying and Siew, Audrey Foong Kow and Tham, Chau Ling and Ming, Tatt Lee (2022) Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms. Frontiers in Pharmacology, 13. art. no. 1032069. pp. 1-15. ISSN 1663-9812 https://www.frontiersin.org/articles/10.3389/fphar.2022.1032069/full 10.3389/fphar.2022.1032069
spellingShingle Chen, Li
Jiang, Xudong
Gao, Si
Liu, Xueping
Gao, Ying
Siew, Audrey Foong Kow
Tham, Chau Ling
Ming, Tatt Lee
Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms
title Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms
title_full Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms
title_fullStr Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms
title_full_unstemmed Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms
title_short Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms
title_sort sensitization effect of kaempferol from persimmon leaves on hepg2 hepatoma cells with abt-199 resistance and its molecular mechanisms
url http://psasir.upm.edu.my/id/eprint/103172/
http://psasir.upm.edu.my/id/eprint/103172/
http://psasir.upm.edu.my/id/eprint/103172/